In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Anti-thrombotic prevention and treatment in Type 2 Diabetes Mellitus

Webinar from the ESC Working Groups on Thrombosis and Aorta & Peripheral Vascular Diseases

23/01/2018 18:00 23/01/2018 19:00 Europe/Paris Anti-thrombotic prevention and treatment in Type 2 Diabetes Mellitus ESC Working Group on Thrombosis specialty-productionmanagement@escardio.org DD/MM/YYYY
ESC Working Group on Thrombosis
Diabetes and the Heart
Anticoagulants
Antiplatelet Drugs
Cardiovascular Pharmacotherapy
Venous Thromboembolism
Treatment
Online
event

Focus on

Learning Objectives:

By attending this Webinar the participants will learn:

  • To illustrate the characteristics of platelet activation and the clinical pharmacology of anti-thrombotic drugs in patients with diabetes
  • To offer an overview of the available evidence on anti-thrombotic therapies in diabetic patients with CAD and/or PAD
  • To discuss the unmet clinical needs regarding anti-thrombotic therapy in patients with diabetes


Watch the webinar recording

 

Faculty

Speakers

 vlachopoulos_charalambos-2015.jpgAssociate Professor Vlachopoulos Charalambos, FESC
Hippokration Hospital
1St Cardiology Department
Athens, Greece

Rocca-Bianca-2016.jpgAssociate Professor Bianca Rocca 
Catholic University School Of Medicine
Pharmacology
Rome, Italy 

 Host

aboyans_v-2016.jpg

Professor Victor Aboyans, FESC
CHRU Dupuytren Limoges
Cardiology
Limoges, France

 Session information

 This webinar addresses:

  • General cardiologists
  • Cardiologists specialising in Peripheral Artery Diseases (PAD) and Coronary Artery Diseases (CAD) where in-depth coverage of all relevant conditions
  • Cardiologists, General Internal doctors and specialists in angiology, pharmacotherapy, interventional cardiologists and electrophysiologists dealing with atrial fibrillation
  • Clinical cardiologists, who would benefit from access to specific courses relating to PAD & CAD.
  • Physicians involved in diagnosis and care of PAD & CAD

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide feedback live.

 Technical settings

The webinar is available on PC and Tablets. The use of a smartphone is not recommended. For the best viewing experience, a high-speed Internet connection is required (minimum 2 Mbps).

Please make sure that the firewall does not prevent the connection to the webinar.